Mannose receptor-targeted vaccines

Bibliography

• STAHL PD: The mannose receptor and other macrophage lectins. Curt: Opin. Immunol (1992) 4:49–52.
   PubMed Web of Science ®Google Scholar
• UCCINI S, SIRIANNI MC, VINCENZI L et al.: Kaposi's sarcoma cells express the macrophage-associated antigen mannose receptor and develop in peripheral blood cultures of Kaposi's sarcoma patients. Am. Pathol (1997) 150:929–938.
   PubMed Web of Science ®Google Scholar
• MAGNUSSON S, BERG T: Endocytosis of ricin by rat liver cells in vivo and in vitro is mainly mediated by mannose receptors on sinusoidal endothelial cells. Biochem. (1993) 291:749–755.
   Google Scholar
• NOORMAN F, BRAAT EA, BARRETT-BERGSHOEFF M et al.: Monoclonal antibodies against the human mannose receptor as a specific marker in flow cytometry and immunohistochemistry for macrophages.' Leukoc. Biol. (1997) 61:63–72.
   PubMed Web of Science ®Google Scholar
• SALLUSTO F, CELLA M, DANIELI C, LANZAVECCHIA A: Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokine and bacterial products.' Exp. Med. (1995) 182:389–400.
   PubMed Web of Science ®Google Scholar
• MOMMAAS AM, MULDER AA, JORDENS R et al.: Human epidermal Langerhans cells lack functional mannose receptors and a fully developed endosomal/ lysosomal compartment for loading of HLA class II molecules. f.ir.J Immunol (1999) 29:571–580.
   Web of Science ®Google Scholar
• GUO M, GONGS, MARIC S, MISULOVIN Z et al.: A monoclonal antibody to the DEC-205 endocytosis receptor on human dendritic cells. Hum. Immunol (2000) 61:729–738.
   PubMed Web of Science ®Google Scholar
• WOLLENBERG A, MOMMAAS AM, OPPEL T et al.: Expression and function of the mannose receptor CD 206 on epidermal dendritic cells in inflammatory skin diseases.ffavest. Dermatol (2002) 118:327–334.
   Google Scholar
• STAHL PD, EZEKOWITZ RA: The mannose receptor is a pattern recognition receptor involved in host defense. Carr. Opin. Immunol (1998) 10:50–55.
   PubMed Web of Science ®Google Scholar
• •Review and discussion of the role of the MR in linking innate and adaptive immune responses.
   Google Scholar
• APOSTOLOPOULOS V, MCKENZIE IF: Role of mannose receptor in the immune response. Carr: Ma Med. (2001) 1:469–474.
   PubMedGoogle Scholar
• ••Short review on the MR as a target forvaccine and drug delivery.
   Google Scholar
• GORDON S: Pattern recognition receptors. Doubling up for the innate immune response. Cell (2002) 111:927–930.
   Google Scholar
• TAYLOR ME: Structure and function ofthe macrophage mannose receptor. In: Results and Problems in Cell Differentiation (Volume 33). Mammalian Carbohydrate Recognition Systems.Crocker PR (Ed.), Springer-Verlag, Berlin, and Heidelberg GmbH & Co., Germany (2001):105–121.
   Google Scholar
• EZEKOWITZ RA, SASTRY K, BAILLY P, WARNER A: Molecular characterization of the human macrophage mannose receptor: demonstration of multiple carbohydrate recognition-like domains and phagocytosis of yeasts in Cos-1 cells. J. Exp. Med. (1990) 172:1785–1794.
   PubMed Web of Science ®Google Scholar
• LINEHAN SA, MARTINEZ-POMARES L, STAHL PD, GORDON S: Mannose receptor and its putative ligands in normal murine lymphoid and nonlymphoid organs: in situ expression of mannose receptor by selected macrophages, endothelial cells, perivascular microglia and mesangial cells, but not dendritic cells.Exp. Med. (1999) 189: 1961-1972.
   Google Scholar
• MARSHALL A, GORDON S: Commentary: C-type lectins on the macrophage cell surface-recent findings. Eur. Immunol (2004) 34:18–24.
   PubMed Web of Science ®Google Scholar
• KATO M, NEIL TK, FEARNLEY DB, MCLELLAN AD, VUKOVIC S, HART DN: Expression of multilectin receptors and comparative FITC-dextran uptake by human dendritic cells. Int. Immunol (2000) 12:1511–1519.
   PubMed Web of Science ®Google Scholar
• GEIJTENBEEK TB, VAN VLIET SJ, ENGERING A, HART BA,VAN KOOYK Y: Self and non-self recognition by C-type lectins on dendritic cells. Annu. Rev Immunol (2004) 22:33–54.
   PubMed Web of Science ®Google Scholar
• ••Comprehensive review of the role of CLRson DCs.
   Google Scholar
• EZEKOWITZ RA, WILLIAMS DJ, KOZIEL H et al.: Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor. Nature (1991) 351:155–158.
   PubMed Web of Science ®Google Scholar
• MANSOUR MK, SCHLESINGER LS, LEVITZ SM: Optimal T cell responses toCryptococcus neoformans mannoprotein are dependent on recognition of conjugated carbohydrates by mannose receptors.Immunol (2002) 168:2872–2879.
   Web of Science ®Google Scholar
• ZHANG J, ZHU J, IMRICH A, CUSHION M, KINANE BT, KOZIEL H: Pneumocystis activates human alveolar macrophage NF-icB signaling through mannose receptors. Infect. Immun. (2004) 72:3147–3160.
   PubMed Web of Science ®Google Scholar
• ROMANI L, MONTAGNOLI C, BOZZA S et al.: The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. hat. Immunol (2004) 16:149–161.
   Web of Science ®Google Scholar
• D'OSTIANI CE DEL SERO G, BACCI A,MONTAGNOLI C et al.: Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans: Implications for initiation of T helper cell immunity in vitro and in vivo. I Exp. Med. (2000) 191:1661–1673.
   Google Scholar
• YAMAMOTO Y, KLEIN TW,FRIEDMAN H: Involvement of mannose receptor in cytokine interleukin-1 beta (IL-1p), IL-6 and granulocyte-macrophage colony-stimulating factor responses, but not in chemokine macrophage inflammatory protein 1 beta (MIP-13), MIP-2 and KC responses, caused by attachment of Candida albicansto macrophages. Infect. Immun. (1997) 65:1077–1082.
   PubMed Web of Science ®Google Scholar
• VAN KOOYK Y, ENGERING A, LEKKERKERKER AN et al.: Pathogens use carbohydrates to escape immunity induced by dendritic cells. Curt: Opin. Immunol (2004) 16:488–493.
   PubMed Web of Science ®Google Scholar
• •Review and discussion of recent findings on how pathogens subvert CLRs on DCs.
   Google Scholar
• TURVILLE S, WILKINSON J, CAMERON P, DABLE J, CUNNINGHAM AL:The role of dendritic cell C-type lectin receptors in HIV pathogenesis. Leukoc. Biol (2003) 74:710–718.
   PubMed Web of Science ®Google Scholar
• NGUYEN DG, HILDRETH JE: Involvement of macrophage mannose receptor in the binding and transmission of HIV by macrophages. Ear: I Immunol (2003) 33:483–493.
   PubMed Web of Science ®Google Scholar
• ENGERING A, GEIJTENBEEK TBH, VAN KOOYK Y: Immune escape through C-type lectins on dendritic cells. Trends Immunol (2002) 23:480–485.
   PubMed Web of Science ®Google Scholar
• MCKENZIE EJ, YUN-PENG S, MARTINEZ-POMARES L: The mannose receptor, a bifunctional lectin with roles in homeostasis and immunity. Trends Clycosci. Clycotech. (2002) 14:273–283.
   Google Scholar
• LINEHAN SA,MARTINEZ-POMARES L, GORDON S: Mannose receptor and scavenger receptor: two macrophage pattern recognition receptors with diverse functions in tissue homeostasis and host defense. Adv. Exp. Med. Biol. (2000) 479:1–14.
   PubMed Web of Science ®Google Scholar
• •A review focusing on the divergent functions of the MR.
   Google Scholar
• FIETE D, BERANEK MC, BAENZIGER JU: The macrophage/ endothelial cell mannose receptor cDNA encodes a protein that binds oligosaccharides terminating with SO4-4-GalNAcI31,4 GlcNAcI3 or Man at independent sites. Proc. Natl. Acad. Sci. USA (1997) 94:11256–11261.
   PubMed Web of Science ®Google Scholar
• SIMPSON DZ, HITCHEN PG, ELMHIRST EL, TAYLOR ME: Multiple interactions between pituitary hormones and the mannose receptor. Biochem. (1999) 343:403–411.
   Google Scholar
• SHEPHERD VL, KONISH MG, STAHL PD: Dexamethasone increases expression of mannose receptors and decreases extracellular lysosomal enzyme accumulation in macrophages. J. Biol. Chem. (1985) 260:160–164.
   PubMed Web of Science ®Google Scholar
• LINEHAN SA,MARTINEZ-POMARES L, DA SILVA RP, GORDON S: Endogenous ligands of carbohydrate recognition domains of the mannose receptor in murine macrophages, endothelial cells and secretory cells: potential relevance to inflammation and immunity. Eur. I Immunol (2001) 31:1857–1866.
   PubMed Web of Science ®Google Scholar
• DONG X, STORKUS WJ, SALTER RD: Binding and uptake of agalactosyl IgG by mannose receptor on macrophages and dendritic cells. Immunol (1999) 163:5427–5434.
   Web of Science ®Google Scholar
• LEE SJ, EVERS S, ROEDER D,PARLOW AF et al.: Mannose receptor-mediated regulation of serum glycoprotein homeostasis. Science (2002) 295:1898–1901.
   Google Scholar
• •First description of MR-deficient mice.
   Google Scholar
• IRJALA H, ALANEN K, GRENMAN R et al.: Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. Cancer Res. (2003) 63:4671–4676.
   PubMed Web of Science ®Google Scholar
• IRJALA H, JOHANSSON EL,GRENMAN R et al.: Mannose receptor is a novel ligand for L-selectin and mediates lymphocyte binding to lymphatic endothelium. I Exp. Med. (2001) 194:1033–1041.
   Google Scholar
• JORDENS R, THOMPSON A,AMONS R, KONING F: Human dendritic cells shed a functional form of the mannose receptor. hat. Immunol (1999) 11:1775–1780.
   Web of Science ®Google Scholar
• MARTINEZ-POMARES L,MAHONEY JA, KAPOSZTA R, LINEHAN SA, STAHL PD,GORDON S: A functional soluble form of the murine mannose receptor is produced by macrophages in vitro and is present in mouse serum. Biol. Chem. (1998) 273:23376–23380.
   Web of Science ®Google Scholar
• •Initial study on a soluble form of MR.
   Google Scholar
• MARTINEZ-POMARES L,KOSCO-VILBOIS M, DARLEY E et al: Fc chimeric protein containing the cysteine-rich domain of the murine mannose receptor binds to macrophages from splenic marginal zone and lymph node subcapsular sinus and to germinal centers. J. Exp. Med. (1996) 184:1927–1937.
   PubMed Web of Science ®Google Scholar
• AGNES MC, TAN A, JORDENS R et al: Strongly increased efficiency of altered peptide ligands by mannosylation. Int. Immunol (1998) 10:1299–1304.
   PubMed Web of Science ®Google Scholar
• TAN MC, MOMMAAS AM,DRUFHOUT JW et al.: Mannose receptor-mediated uptake of antigens strongly enhances HLA class II-restricted antigen presentation by cultured dendritic cells. Eur. Immunol (1997) 27:2426–2435.
   Google Scholar
• ••One of the first reports, together with [44],on the enhanced efficiency of processing and presentation of mannosylated antigens by DCs.
   Google Scholar
• VAN BERGEN J, OSSENDORP F, JORDENS R et al.: Get into the groove! Targeting antigens to MHC class II. Immunol Rev (1999) 172:87–96.
   PubMed Web of Science ®Google Scholar
• ENGERING A, CELLA M, FLUITSMA D et al.: The mannose receptor functions as a high capacity and broad specificity antigen receptor in human dendritic cells. Ear: J. Immunol (1997) 27:2417–2425.
   PubMed Web of Science ®Google Scholar
• ••One of the first reports, together with [42],on the enhanced efficiency of processing and presentation of mannosylated antigens by DCs.
   Google Scholar
• HATTORI Y, KAWAKAMI S, SUZUKI S, YAMASHITA F, HASHIDA M: Enhancement of immune responses byDNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochem. Biophys. Res. Commun. (2004) 317:992–999.
   PubMed Web of Science ®Google Scholar
• FOGED C, ARIGITA C, SUNDBLAD A, JISKOOT W, STORM G, FROKJAER S: Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. Vaccine (2004) 22:1903–1913.
   PubMed Web of Science ®Google Scholar
• ARIGITA C, BEVAART L, EVERSE LA et al.: Liposomal meningococcal B vaccination: Role of dendritic cell targeting in the development of a protective immune response. Infect. Inman. (2003) 71:5210–5218.
   PubMed Web of Science ®Google Scholar
• SPROTT GD, DICAIRE CJ, GURNANI K, SAD S, KRISHNAN L: Activation of dendritic cells by liposomes prepared from phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette-Guerin and adjuvant activity in vivo. Infect. Immun. (2004) 72:5235–5246.
   PubMed Web of Science ®Google Scholar
• APOSTOLOPOULOS V, PIETERSZ GA, GORDON S, MARTINEZ-POMARES L, MCKENZIE IF: Aldehyde-mannan antigen complexes target the MHC class I antigen presentation pathway. Ear: Immunol (2000) 30:1714–1723.
   Google Scholar
• ••Critical demonstration of howMR-targeted vaccines can elicit different immune responses depending on the MR-ligand interaction.
   Google Scholar
• APOSTOLOPOULOS V, PIETERSZ GA, MCKENZIE IF: Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine (1996) 14:930–938.
   PubMed Web of Science ®Google Scholar
• APOSTOLOPOULOS V, BARNES N, PIETERSZ GA, MCKENZIE IF: Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses. Vaccine (2000) 18:3174–3184.
   PubMed Web of Science ®Google Scholar
• VAUGHAN HA, HO DW,KARANIKAS V et al: Induction of humoral and cellular responses in cynomolgus monkeys immunized with mannan-human MUC1 conjugates. Vaccine (1999) 17:2740–2752.
   PubMed Web of Science ®Google Scholar
• VAUGHAN HA, HO DW, KARANIKAS V et al: The immune response of mice and cynomolgus monkeys to macaque mucin 1-mannan. Vaccine (2000) 18:3297–3309.
   PubMed Web of Science ®Google Scholar
• KARANIKAS V, HWANG LA,PEARSON J et al.: Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J. Clin. Invest. (1997) 100:2783–2792.
   Google Scholar
• •First paper describing the clinical application of a therapeutic cancer vaccine targeting the MR.
   Google Scholar
• KARANIKAS V, THYNNE G, MITCHELL P et al.: Mannan mucin-1 peptide immunization: Influence of cyclophosphamide and the route of injection. J. Immunother. (2001) 24:172–183.
   Web of Science ®Google Scholar
• KARANIKAS V, LODDING J, MAINO VC, MCKENZIE IF: Flow cytometric measurement of intracellular cytokines detects immune responses in MUC1 immunotherapy. Clin. Cancer Res. (2000) 6:829–837.
   PubMed Web of Science ®Google Scholar
• GU XG, SCHMITT M, HIASA A et al: A novel hydrophobized polysaccharide/ oncoprotein complex vaccine inducesM vitro and in vivo cellular and humoral immune responses against HER2-expressing murine sarcomas. Cancer Res. (1998) 58:3385–3390.
   PubMed Web of Science ®Google Scholar
• TODA S, ISHII N, OKADA E et al: HIV-1-specific cell-mediated immune responses induced by DNA vaccination were enhanced by mannan-coated liposomes and inhibited by anti-interferon-y antibody. Immunol (1997) 92:111–117.
   PubMed Web of Science ®Google Scholar
• SASAKI S, FUKUSHIMAJ, ARAI H et al.: Human immunodeficiency virus type-1-specific immune responses induced by DNA vaccination are greatly enhanced by mannan-coated diC14-amidine. Eur. Immunol (1997) 27:3121–3129.
   PubMed Web of Science ®Google Scholar
• CUI Z, MUMPER RJ: Topical immunization using nanoengineered genetic vaccines. Control. Release (2002) 81:173–184.
   PubMed Web of Science ®Google Scholar
• RAMAKRISHNA V, TREML J, VITALE Let al.: Mannose receptor targeting of tumor antigen pme117 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules. j. Immunol (2004) 172:2845–2852.
   Google Scholar
• •First paper describing antigen-targeting to the MR using a MR-specific mAb.
   Google Scholar
• HE LZ, RAMAKRISHNA V, CONNOLLY JE et al: A novel human cancer vaccine elicits cellular responses to the tumor-associated antigen, human chorionic gonadotropinp. Clin. Cancer Res. (2004) 10:1920–1927.
   PubMed Web of Science ®Google Scholar
• FRISON N, TAYLOR ME, SOILLEUX E et al.: Oligolysine-based oligosaccharide clusters: selective recognition andendocytosis by the mannose receptor and dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3)-grabbing nonintegrin. I Biol. Chem. (2003) 278:23922–23929.
   Web of Science ®Google Scholar
• GEIJTENBEEK TB, VAN VLIET SJ, KOPPEL EA et al.: Mycobacteria target DC-SIGN to suppress dendritic cell function. Exp. Med. (2003). 197:7–17.
   PubMed Web of Science ®Google Scholar
• HUDSON PJ, SOURIAU C: Engineered antibodies. Nat. Med. (2003) 9:129–134.
   PubMed Web of Science ®Google Scholar
• CHIEPPA M, BIANCHI G, DONI A et al.: Cross-linking of the mannose receptor on monocyte-derived dendritic cells activates an anti-inflammatory immunosuppressive program. J. Immunol (2003) 171:4552–4560.
   PubMed Web of Science ®Google Scholar
• ••Highlights the differences in signallingevents resulting from MR interactions with different ligands or mAbs.
   Google Scholar
• OPANASOPIT P, SHIRASHI K, NISHIKAWA M et al.: In vivo recognition of mannosylated proteins by hepatic mannose receptors and mannan-binding protein. Am. j Physiol Castrointest. Liver Physiol (2001) 280:G879–G889.
   PubMed Web of Science ®Google Scholar
• ARIIZUMI K, SHEN GL, SHIKANO S et al.: Identification of a novel, dendritic cell-associated molecule, Dectin-1, by subtractive cDNA cloning. I Biol. Chem. (2000) 275:20157–20167.
   Web of Science ®Google Scholar
• GRUNEBACH F, WECK MM, REICHERT J, BROSSART P: Molecular and functional characterization of human Dectin-1. Exp. Hematol (2002) 30:1309–1315.
   PubMed Web of Science ®Google Scholar
• HERRE J, MARSHALL AJ, CARON E et al: Dectin-1 utilizes novel mechanisms for yeast phagocytosis in macrophages. Blood (2004) (In Press).
   Google Scholar
• MAHNKE K, GUO M, LEES et al: The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II positive lysosomal compartments. J. Cell Biol. (2000) 151:673–684.
   PubMed Web of Science ®Google Scholar
• ••First in a series of papers demonstratingthe efficiency and opposing effects when antigens are targeted to DEC-205 under varying conditions.
   Google Scholar
• CONNOLLY JE, TREML JF,FANGER MW, KELER T, WALLACE PK: Colocalization of mannose receptor targeting antibody with MHC class I presentation pathway in human dendritic cells. Keystone Symposia - Den dritic Cells:Interfaces with Immunobiology and Medicine.Keystone, CO, USA (3–8 March 2003).
   Google Scholar
• TIETZE C, SCHLESINGER P,STAHL PD: Mannose-specific endocytosis receptor of alveolar macrophages: demonstration of two functionally distinct intracellular pools of receptor and their roles in receptor recycling. Cell Biol (1982) 92:417–424.
   PubMed Web of Science ®Google Scholar
• NAPPER CE, TAYLOR ME: The mannosereceptor fails to enhance processing and presentation of a glycoprotein antigen in transfected fibroblasts. Clycobiol. (2004) 14:7C–12C.
   Google Scholar
• BONIFAZ L, BONNYAY D,MAHNKE K, RIVERA M,NUSSENZWEIG MC, STEINMAN RM: Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. Exp. Med. (2002) 196:1627–1638.
   PubMed Web of Science ®Google Scholar
• HAWIGER D, INABA K, DORSETT Y et al.: Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. I Exp. Med. (2001) 194:769–779.
   PubMed Web of Science ®Google Scholar
• ENGERING A, GEIJTENBEEK TB, VAN VLIET SJ et al.: The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J. Immunol (2002) 168:2118–2126.
   Google Scholar
• DZIONEK A, SOHMA Y, NAGAFUNE J et al.: BDCA-2, a novel plasmacytoid dendritic cell-specific type II C-type lectin, mediates antigen capture and is a potent inhibitor of interferon a/13 induction. .1. Exp. Med. (2001) 194:1823–1834.
   Google Scholar
• BONIFAZ LC, BONNYAY DP, CHARALAMBOUS A et al: In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J. Exp. Med. (2004) 199:815–824.
   PubMed Web of Science ®Google Scholar
• ••Demonstrates the potential of targetingAPCs in vivo with therapeutic vaccines.
   Google Scholar
• PRIGOZY TI, SIELING PA,CLEMENS D et al.: The mannose receptor delivers lipoglycan antigens to endosomes for presentation to T cells by CD1 b molecules. Immunity (1997) 6:187–197.
   Google Scholar
• TSUJI S, MATSUMOTO M,TAKEUCHI 0 et al: Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guerin: involvement of Toll-like 1961receptors. Infect. Immun. (2000) 68:6883–6890.
   PubMed Web of Science ®Google Scholar
• NIGOU J, ZELLE-REISER C, GILLERON M, THURNHER M, PUZO G: Mannosylated fipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. (2001) 166:7477–7785.
   PubMed Web of Science ®Google Scholar
• LEACH DR KRUMMEL MF,ALLISON JP: Enhancement of antitumor immunity by CTLA-4 blockade. Science (1996) 271: 1734-1736.
   Google Scholar
• PHAN GQ, YANG JC, SHERRY P.M et al: Cancer regression and autoimmunityinduced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc. Natl. Acad. Sci. USA (2003) 100:8372–8377.
   Google Scholar
• GUERMONPREZ P, SAVEANU L, KLEIJMEER M et al.: ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells. Nature (2003) 425:397–402.
   PubMed Web of Science ®Google Scholar
• •Together with [86], these studies have elucidated the mechanism by which MR-targeted vaccines may gain access to the MHC class I presentation pathway.
   Google Scholar
• HOUDE M, BERTHOLET S, GAGNON E et al.: Phagosomes are competent organelles for antigen cross-presentation. Nature (2003) 425:402–406.
   PubMed Web of Science ®Google Scholar